Pancuronium (Br) Overview Categories 20 Muscle relaxants and cholinesterase inhibitors Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Pancuronium (Br) Manufacturers of Pancuronium (Br) Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Pancuronium (Br)'s dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 0.01 to 0.02 mg/ kg0.015 (0.015)As recommended.IVIncremental Dose. Overdosage should be avoided in obese patient.0.02 to 0.06 mg/ kg0.04 (0.04)As recommended.IVInitial Dose Paedriatic Dosage (20kg) 0.06 ug/kg0.06 (0.06)As recommended.Intra VenousInitially for Once10 to 20 ug/kg15 (15)As recommended.Intra VenousMaintenance every 30 to 60 min, As Required Neonatal Dosage (3kg) 0.06 ug/kg0.06 (0.06)As recommended.Intra VenousInitially for Once10 to 20 ug/kg15 (15)As recommended.Intra VenousMaintenance every 30 to 60 min, As Required High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Pancuronium (Br) Back to top Manufacturers of Pancuronium (Br) in Pakistan Akhai Brookes Caraway Haji Obs Saydon Back to top Previous Drug Generic - Next Drug Generic